Cas 521266-36-4,(S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester

521266-36-4

Post Buying Request

Basic information

Product Name: (S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester
Synonyms: (S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester
CAS NO:521266-36-4
Molecular Formula:
Molecular Weight: 380.487
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester(521266-36-4)
EPA Substance Registry System: (S)-{2-[6-(4-methoxy-phenyl)-indol-1-yl]-1-methyl-ethyl}-carbamic acid tert-butyl ester(521266-36-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 521266-36-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

521266-36-4 Suppliers

Recommended suppliers

521266-36-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 521266-36-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,1,2,6 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 521266-36:
(8*5)+(7*2)+(6*1)+(5*2)+(4*6)+(3*6)+(2*3)+(1*6)=124
124 % 10 = 4
So 521266-36-4 is a valid CAS Registry Number.

521266-36-4Upstream product

147621-15-6 6-(4-methoxyphenyl)-1H-indole

521266-36-4Downstream Products

521266-36-4Relevant academic research and scientific papers

DPP IV inhibitors

-

, (2008/06/13)

The present invention relates to compounds of formula (I) wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 521266-36-4